Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

<p><strong>Background</strong> There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of adverse drug reactions, examined the eviden...

書誌詳細
主要な著者:	Onakpoya, IJ, Heneghan, CJ, Aronson, JK
フォーマット:	Journal article
言語:	English
出版事項:	BioMed Central 2016

類似資料

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
著者:: Igho J. Onakpoya, 等
出版事項: (2019-03-01)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
著者:: Onakpoya, I, 等
出版事項: (2016)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
著者:: Onakpoya, I, 等
出版事項: (2017)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
著者:: Onakpoya, I, 等
出版事項: (2016)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
著者:: Onakpoya, I, 等
出版事項: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
著者:: Onakpoya, I
出版事項: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
著者:: Onakpoya, I, 等
出版事項: (2017)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
著者:: Onakpoya, IJ, 等
出版事項: (2020)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
著者:: Daniele Sartori, 等
出版事項: (2020-08-01)

Withdrawal of cerivastatin from the world market
著者:: Pitt Bertram, 等
出版事項: (2001-09-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
著者:: Onakpoya, I, 等
出版事項: (2018)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
著者:: Aronson, J
出版事項: (2017)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
著者:: Aronson, J
出版事項: (2008)

Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update
著者:: Jefferson, T, 等
出版事項: (2022)

An agenda for research on adverse drug reactions.
著者:: Aronson, J
出版事項: (2007)

Adverse drug reactions--no farewell to harms.
著者:: Aronson, J
出版事項: (2007)

Pharmacogenetics and adverse drug reactions
著者:: Ferner, R, 等
出版事項: (2010)

REG 462 - Rekabentuk Konkrit
著者:: PPPB, Pusat Pengajian Perumahan Dan Bangunan
出版事項: (1995)

Withdrawn medicines included in the essential medicines lists of 136 countries.
著者:: Onella Charles, 等
出版事項: (2019-01-01)

Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: a systematic review
著者:: Salas-Gama, K, 等
出版事項: (2022)

20.462J / 3.962J Molecular Principles of Biomaterials (BE.462J), Spring 2003
著者:: Irvine, Darrell J.
出版事項: (2003)

The effectiveness and safety of Japanese traditional medicine (Kampo) in the treatment of climacteric symptoms
著者:: Onakpoya, I, 等
出版事項: (2013)

Adverse drug reactions: definitions, diagnosis, and management.
著者:: Edwards, I, 等
出版事項: (2000)

What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries
著者:: Coombs, C, 等
出版事項: (2017)

Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity
著者:: Ferner, RE, 等
出版事項: (2022)

Adverse drug reactions: keeping up to date.
著者:: Aronson, J, 等
出版事項: (2002)

Is It Because I Can or Because of Who I Am?
著者:: María Laura Gonzalez-Canosa, 等
出版事項: (2021-12-01)

Paradoxical reactions: Under-recognized adverse effects of drugs?
著者:: Hauben, M, 等
出版事項: (2006)

National differences in publishing papers on adverse drug reactions.
著者:: Ferner, R, 等
出版事項: (2005)

RMK462 - PENTADBIRAN TANAH FEBRUARI 1998
著者:: PPPB, Pusat Pengajian Perumahan Dan Bangunan
出版事項: (1998)

REG 462 - REKABENTUK KONKRIT JUN 1992
著者:: PPPB, Pusat Pengajian Perumahan Dan Bangunan
出版事項: (1992)

PGT 462: Pengelolaan Dan Penyelidikan Sekolah
著者:: PPIP, Pusat Pengajian Ilmu Pendidikan
出版事項: (1997)

PGT 462 Pengelolaan dan Penyeliaan Sekolah
著者:: PPIP, Pusat Pengajian Ilmu Pendidikan
出版事項: (1997)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
著者:: Aronson, J
出版事項: (2012)

Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016
著者:: Johanna Seifert, 等
出版事項: (2024-11-01)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
著者:: Łukasz Dobrek
出版事項: (2022-08-01)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
著者:: Talbot, J, 等
出版事項: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
著者:: Talbot, J, 等
出版事項: (2012)

SARS-CoV-2 and the role of orofecal transmission: a systematic review
著者:: Heneghan, CJ, 等
出版事項: (2021)

SARS-CoV-2 and the role of fomite transmission: a systematic review
著者:: Onakpoya, IJ, 等
出版事項: (2021)